Dudediligence.

eXoZymes, Inc

EXOZNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$1.7MSep ’24−$1.8MDec ’24−$1.9MMar ’25−$2.4MJun ’25−$2.3MSep ’25−$2.7MDec ’25−$2.4MMar ’26−$2.9MJun ’26
Fiscal years, by the month each ended
LineDec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$70,069none on filenone on file
Operating incomenone on file−$1.8M−$5.9M−$9.7M
Net incomenone on file−$2.0M−$5.9M−$9.2M
Operating cash flownone on file−$1.2M−$8.5M−$6.5M
Free cash flownone on file−$1.5M−$8.9M−$6.7M
Cash$558,570$66,533$9.7M$3.0M
Shares outstandingnone on file6.3M8.4M8.4M